| __timestamp | Ligand Pharmaceuticals Incorporated | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 12122000 | 1488000000 |
| Thursday, January 1, 2015 | 13380000 | 1525000000 |
| Friday, January 1, 2016 | 21221000 | 2111000000 |
| Sunday, January 1, 2017 | 26887000 | 1848000000 |
| Monday, January 1, 2018 | 27863000 | 1213000000 |
| Tuesday, January 1, 2019 | 55908000 | 1010000000 |
| Wednesday, January 1, 2020 | 59392000 | 997000000 |
| Friday, January 1, 2021 | 69012000 | 967000000 |
| Saturday, January 1, 2022 | 36082000 | 838000000 |
| Sunday, January 1, 2023 | 24537000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, innovation is key. Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated have taken distinct paths in their research and development (R&D) investments over the past decade. From 2014 to 2023, Teva consistently outspent Ligand, with R&D expenses peaking in 2016 at over 2 billion dollars. In contrast, Ligand's highest expenditure was in 2021, reaching nearly 69 million dollars. Despite the stark difference in absolute spending, Ligand's R&D expenses grew by approximately 470% from 2014 to 2021, showcasing a significant commitment to innovation. Meanwhile, Teva's spending saw a decline of about 36% from its peak in 2016 to 2023. This divergence highlights the varied strategies these companies employ to maintain their competitive edge in the pharmaceutical industry. As the landscape evolves, monitoring these trends offers valuable insights into the future of drug development and innovation.
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for AbbVie Inc. and Ligand Pharmaceuticals Incorporated
Sanofi vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
R&D Insights: How Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited Allocate Funds
Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
R&D Insights: How Lantheus Holdings, Inc. and Ligand Pharmaceuticals Incorporated Allocate Funds
Research and Development: Comparing Key Metrics for Amicus Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Catalyst Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Ligand Pharmaceuticals Incorporated and Amphastar Pharmaceuticals, Inc.
Ligand Pharmaceuticals Incorporated or Novavax, Inc.: Who Invests More in Innovation?